Tvardi Therapeutics (TVRD)

Profile

Full Name

Tvardi Therapeutics, Inc.

Ticker Symbol

TVRD

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 16, 2025

Indexes

Not included

Website

http://tvarditherapeutics.com

Employees

17

Key Details

Price

$24.61(-2.38%)

Market cap

$230.37M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.85(+15.55% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $24.61
    TVRD price is $24.61

    30-Day Relative Volume

    4.47
    TVRD 30-day relative volume is 4.47

    Price Performance

    Price Most recent change

    -2.38%
    TVRD price was down -2.38% on Jun 27, 2025

    Price YTD change

    +34.04%
    TVRD price is up +34.04% since January 1st

    Price 1-year change

    +124.13%
    TVRD price is up +124.13% year-on-year

    Price 3-year change

    -92.94%
    TVRD price is down -92.94% over the past 3 years

    Price Range

    Price All-time high

    $1067.29
    TVRD price is currently -97.69% below its historical high of $1067.29

    Price 3-year low

    $8.14
    TVRD price is currently +202.48% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $230.37M
    TVRD market capitalization is $230.37 million

    Market cap 3-year change

    -
    TVRD market capitalization 3-year change is unknown

    Market cap All-time high

    $312.56M
    TVRD market capitalization is currently -26.30% below its historical high of $312.56 million

    Market cap sector rank

    55.89%
    TVRD market capitalization is higher than 55.89% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    TVRD shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    TVRD shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.38
    TVRD beta is 0.38

    200-day SMA

    $16.00
    TVRD price is currently +53.83% above its 200-day simple moving average

    50-day SMA

    $25.56
    TVRD price is currently -3.71% below its 50-day simple moving average

    RSI

    45.56
    TVRD 14-day relative strength index is 45.56

    Volume

    4.47
    TVRD 30-day relative volume is 4.47

    ATR

    $2.30
    TVRD average true range is $2.30

    10-day Historical Volatility

    87.25%
    TVRD 10-day historical volatility is 87.25%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    TVRD annual revenue value is unknown

    Revenue Analysts estimate

    $520.00K
    TVRD annual revenue is currently equal to the consensus analysts' forecast

    Revenue 1-year change

    -
    TVRD annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    TVRD annual revenue is unknown

    EPS

    EPS

    -$1.85
    TVRD annual earnings per share is -$1.85

    EPS Analysts estimate

    -$1.90
    TVRD annual earnings per share is currently -2.41% lower than the consensus analysts' forecast

    EPS 1-year change

    +15.55%
    TVRD annual earnings per share is up +15.55% year-on-year

    EPS Sector rank

    40.28%
    TVRD annual earnings per share is higher than 40.28% of companies in Healthcare sector

    Profit

    Gross profit

    -
    TVRD annual gross profit value is unknown

    Gross margin

    -
    TVRD annual gross profit margin value is unknown

    Operating profit

    -$18.66M
    TVRD annual operating income is -$18.66 million

    Operating margin

    -
    TVRD annual operating profit margin value is unknown

    Net income

    -$17.35M
    TVRD annual net profit is -$17.35 million

    Net margin

    -
    TVRD annual net profit margin value is unknown

    Expenses

    Total expenses

    $18.66M
    TVRD annual total expenses is $18.66 million

    Operating expenses

    $18.66M
    TVRD annual total operating expenses is $18.66 million

    Cost of goods sold

    -
    TVRD annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $2.80M
    TVRD annual SGA is $2.80 million

    Depreciation and amortization

    $95.00K
    TVRD annual depreciation & amortization is $95.00 thousand

    Interest expense

    $0.00
    TVRD annual interest expense is $0.00

    Income tax

    -
    TVRD annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$17.35M
    TVRD annual earnings before interest & taxes is -$17.35 million

    EBITDA

    -$17.25M
    TVRD annual EBITDA is -$17.25 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $27.00M
    TVRD annual total assets is $27.00 million

    Non current assets

    $843.00K
    TVRD annual long term assets is $843.00 thousand

    Current assets

    $26.16M
    TVRD annual total current assets is $26.16 million

    Cash and cash equivalents

    $22.92M
    TVRD annual cash & cash equivalents is $22.92 million

    Accounts receivable

    -
    TVRD annual accounts receivable value is unknown

    Inventory

    -
    TVRD annual inventory value is unknown

    Liabilities

    Total liabilities

    $89.06M
    TVRD annual total liabilities is $89.06 million

    Long term liabilities

    $85.78M
    TVRD annual total long term liabilities is $85.78 million

    Current liabilities

    $3.28M
    TVRD annual total current liabilities is $3.28 million

    Accounts payable

    $1.61M
    TVRD annual accounts payable is $1.61 million

    Debt

    Total debt

    $368.00K
    TVRD annual total debt is $368.00 thousand

    Total debt 1-year change

    -18.22%
    TVRD annual total debt is down -18.22% year-on-year

    Long term debt

    $275.00K
    TVRD annual long term debt is $275.00 thousand

    Short term debt

    $93.00K
    TVRD annual short term debt is $93.00 thousand

    Equity & Capital

    Shareholders equity

    -$62.06M
    TVRD annual stockholders equity is -$62.06 million

    Book value

    -$62.06M
    TVRD annual book value is -$62.06 million

    Retained earnings

    -$62.84M
    TVRD annual retained earnings is -$62.84 million

    Working capital

    $22.88M
    TVRD annual working capital is $22.88 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$21.04M
    TVRD annual cash flow from operations is -$21.04 million

    Cash from operations 1-year change

    -17.77%
    TVRD annual cash flow from operations is down -17.77% year-on-year

    Cash from investing

    $22.47M
    TVRD annual cash flow from investing activities is $22.47 million

    Cash from investing 1-year change

    +202.13%
    TVRD annual cash flow from investing activities is up +202.13% year-on-year

    Cash from financing

    $2000.00
    TVRD annual cash flow from financing activities is $2000.00

    Cash from financing 1-year change

    -50%
    TVRD annual cash flow from financing activities is down -50% year-on-year

    CAPEX

    CAPEX

    -
    TVRD annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    TVRD annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$21.04M
    TVRD annual free cash flow is -$21.04 million

    Free cash flow 1-year change

    -17.44%
    TVRD annual free cash flow is down -17.44% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    TVRD annual gross profit margin value is unknown

    Operating margin

    -
    TVRD annual operating profit margin value is unknown

    Net margin

    -
    TVRD annual net profit margin value is unknown

    ROA & ROE

    ROA

    -64.25%
    TVRD annual return on assets is -64.25%

    ROE

    27.95%
    TVRD annual return on equity is 27.95%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TVRD price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TVRD price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -28.54
    TVRD price to book ratio is -28.54

    PB ratio Sector rank

    1.72%
    TVRD price to book ratio is higher than 1.72% of companies in Healthcare sector

    PS Ratio

    PS ratio

    89.67
    TVRD price to sales ratio is 89.67

    PS ratio Sector rank

    94.7%
    TVRD price to sales ratio is higher than 94.7% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $196.15M
    TVRD enterprise value is $196.15 million

    Enterprise value Sector rank

    55.56%
    TVRD enterprise value is higher than 55.56% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -96.20
    TVRD EV/EBITDA is -96.20

    EV/EBITDA Sector rank

    2.09%
    TVRD EV/EBITDA is higher than 2.09% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.97
    TVRD annual current ratio is 7.97

    Quick ratio

    -
    TVRD annual quick ratio value is unknown

    Leverage

    Debt to equity

    -0.01
    TVRD annual debt to equity ratio is -0.01

    Interest coverage ratio

    -
    TVRD annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    TVRD piotroski f-score value is unknown

    Altman Z-Score

    -
    TVRD altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jun 12, 25 Piper Sandler
    Overweight
    May 21, 25 Oppenheimer
    Outperform
    Apr 28, 25 Jones Trading
    Buy

    Institutional Ownership

    Screeners with TVRD included

    US stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    Biotechnology industry
    Best performing stocks YTD
    Ex Dividend dates calendar
    • What is the ticker symbol for Tvardi Therapeutics?
    • Does Tvardi Therapeutics pay dividends?
    • What sector is Tvardi Therapeutics in?
    • What industry is Tvardi Therapeutics in?
    • What country is Tvardi Therapeutics based in?
    • When did Tvardi Therapeutics go public?
    • Is Tvardi Therapeutics in the S&P 500?
    • Is Tvardi Therapeutics in the NASDAQ 100?
    • Is Tvardi Therapeutics in the Dow Jones?
    • When does Tvardi Therapeutics report earnings?

    What is the ticker symbol for Tvardi Therapeutics?

    The ticker symbol for Tvardi Therapeutics is NASDAQ:TVRD

    Does Tvardi Therapeutics pay dividends?

    No, Tvardi Therapeutics does not pay dividends

    What sector is Tvardi Therapeutics in?

    Tvardi Therapeutics is in the Healthcare sector

    What industry is Tvardi Therapeutics in?

    Tvardi Therapeutics is in the Biotechnology industry

    What country is Tvardi Therapeutics based in?

    Tvardi Therapeutics is headquartered in United States

    When did Tvardi Therapeutics go public?

    Tvardi Therapeutics's initial public offering (IPO) was on April 16, 2025

    Is Tvardi Therapeutics in the S&P 500?

    No, Tvardi Therapeutics is not included in the S&P 500 index

    Is Tvardi Therapeutics in the NASDAQ 100?

    No, Tvardi Therapeutics is not included in the NASDAQ 100 index

    Is Tvardi Therapeutics in the Dow Jones?

    No, Tvardi Therapeutics is not included in the Dow Jones index

    When does Tvardi Therapeutics report earnings?

    The date for Tvardi Therapeutics's next earnings report has not been announced yet
    On this page